Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2020

View Archived Issues

Another obstacle to universal flu vaccine

ORIC Pharmaceuticals' OP-4954 displays selective glucocorticoid receptor antagonism

Promising preclinical data for novel lymph node targeting COVID-19 vaccine

Phosphodiesterase PDE3A and PDE3B inhibitors described by Bayer, The Broad Institute

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent ADORA2A/B antagonists

Jiangsu Chia Tai Tianqing Pharmaceutical discovers HBV capsid assembly inhibitors

New opioid receptor ligands identified at Yangtze River Pharmaceutical

Esteve presents dual sigma1 and mu-opioid receptor ligands

Genmab initiates first-in-human study of GEN-1044

Takeda starts enrollment in first-in-human trial of TAK-102

Enrollment ongoing in phase I/II study of TAEK-VAC-HerBy vaccine

First participant vaccinated in phase III study of MenABCWY meningitis vaccine candidate

Tankyrase inhibition with OM-153 shows potential for immuno-oncology

Ascletis completed bridging study of ASC-18 FDC pill for the treatment of hepatitis C

Repurposing of low-cost generic nafamostat as COVID-19 therapy

First healthy volunteer dosed in phase I clinical program of IMU-856

Positive early data for lead mRNA COVID-19 vaccine candidate BNT-162b2

Orally active STING agonists stimulate innate immunity

FDA approves Kesimpta for the treatment of relapsing multiple sclerosis

Imfinzi receives Japanese approval for the treatment of extensive-stage SCLC

First-in-human proof-of-concept trial for HBV treatment ALG-010133 begins

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...